This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

Endoscopic Ultrasound (EUS) Features of Chronic Pancreatitis

This study has been terminated.
(The PI left and then the PI who would be taking over has left. No other investigator wanted to take the study since not sponsored)
Information provided by (Responsible Party):
Indiana University Identifier:
First received: September 26, 2011
Last updated: February 29, 2016
Last verified: February 2016
The purpose of this study is to correlate Endoscopic Ultrasound (EUS) criteria for chronic pancreatitis with surgical pathology.

Condition Intervention
Chronic Pancreatitis Other: chronic pancreatitis

Study Type: Observational
Study Design: Time Perspective: Prospective
Official Title: Endoscopic Ultrasound (EUS) Features of Chronic Pancreatitis: A Prospective Correlation With Intraoperative Findings and Surgical Pathology

Resource links provided by NLM:

Further study details as provided by Indiana University:

Enrollment: 100
Study Start Date: October 2010
Study Completion Date: September 2014
Primary Completion Date: September 2014 (Final data collection date for primary outcome measure)
Groups/Cohorts Assigned Interventions
Chronic Pancreatitis Other: chronic pancreatitis
No intervention, subjects followed through surgery


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
Patients undergoing EUS

Patients who are eligible are individuals who have:

  • normal pancreas
  • suspected chronic pancreatitis
  • established chronic pancreatitis (by ERCP, MRI, previous EUS, CT)
  • pancreatic cancer

Patients who are not eligible are individuals who have:

• an uncorrectable coagulopathy (platelet <50,000, INR>1.5), or bleeding disorder, or are unable to discontinue anticoagulation 5-7 days prior to EUS (aspirin and bridging therapy with lovenox are allowed, clopidogrel is not allowed)

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01442454

United States, Indiana
Indiana University Hospital
Indianapolis, Indiana, United States, 46202
Sponsors and Collaborators
Indiana University
  More Information

Responsible Party: Indiana University Identifier: NCT01442454     History of Changes
Other Study ID Numbers: 1008-15
Study First Received: September 26, 2011
Last Updated: February 29, 2016

Keywords provided by Indiana University:
chronic pancreatitis

Additional relevant MeSH terms:
Pancreatitis, Chronic
Pancreatic Diseases
Digestive System Diseases processed this record on September 21, 2017